Cerebral Aneurysm
0
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
StrykerCA - San Jose
2 programsCoil Embolization with larger Diameter CoilsN/A1 trial
Surpass Flow DiverterN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
UNION therapeuticsHeparin Sodium
StrykerSurpass Flow Diverter
StrykerCoil Embolization with larger Diameter Coils
Clinical Trials (3)
Total enrollment: 1,209 patients across 3 trials
Exploration of Anticoagulation Program in Cerebral Aneurysm and Arteriovenous Malformations With Hybrid Operation 2
Start: Sep 2016Est. completion: Aug 2021408 patients
N/AUnknown
Surpass Flow Diverter for Intracranial Aneurysms: SURMOUNT Registry Data Collection
Start: Mar 2015Est. completion: Dec 2019150 patients
N/ATerminated
Framing Eighteen Coils in Cerebral Aneurysms Trial
Start: Dec 2012Est. completion: Feb 2024651 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.